abnormal seizure response to pharmacological agent_Szv3<C57BL/6J>/Szv3<DBA/2J>

http://metadb.riken.jp/0000950IC57BL6JDBA2JSzv3C57BL6JSzv3DBA2JSzv3C57BL6JSzv3DBA2J

abnormal seizure response to pharmacological agent_Szv3<C57BL/6J>/Szv3<DBA/2J>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• seizure severity 3
  http://metadb.riken.jp/db/mgi_rdf/MGI:1098789

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Szv3<C57BL/6J>/Szv3<DBA/2J>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Szv3<C57BL/6J>|Szv3<DBA/2J>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: C57BL/6J * DBA/2J

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal seizure response to pharmacological agent
  http://purl.obolibrary.org/obo/MP_0000950

文献

http://purl.org/net/cito/citesAsAuthority

• T N. Ferraro, et.al., Quantitative genetic study of maximal electroshock seizure threshold in mice: evidence for a major seizure susceptibility locus on distal chromosome 1., Genomics, 2001, 75
  http://rdf.ncbi.nlm.nih.gov/pubmed/11472065